“…Several functions of nuclear Rac1 have been described, including controlling nuclear shape ( Navarro-Lerida et al, 2015 ), stimulating rRNA synthesis ( Justilien et al, 2017 ), promoting the cell cycle ( Michaelson et al, 2008 ), inducing neoplastic transformation ( Huff et al, 2013 ), and enhancing malignancy ( Huff et al, 2013 ; Navarro-Lerida et al, 2015 ; Justilien et al, 2017 ). Rac1 is activated in the nucleus by the GEF ECT2 ( Huff et al, 2013 ; Justilien et al, 2017 ), and it is inactivated by a nuclear variant of β1-chimaerin ( Casado-Medrano et al, 2020 ). The binding of prenylated Rac1 to SmgGDS-558 provides a way for prenylated Rac1 to enter the nucleus and participate in these signaling pathways.…”